• Home
  • Search Results
  • Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations.

Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations.

Journal of pharmacological and toxicological methods (2014-08-26)
Xiannu Jin, Thu-Lan Luong, Necole Reese, Heather Gaona, Vanessa Collazo-Velez, Chau Vuong, Brittney Potter, Jason C Sousa, Raul Olmeda, Qigui Li, Lisa Xie, Jing Zhang, Ping Zhang, Greg Reichard, Victor Melendez, Sean R Marcsisin, Brandon S Pybus

Malaria is a major health concern and affects over 300million people a year. Accordingly, there is an urgent need for new efficacious anti-malarial drugs. A major challenge in developing new anti-malarial drugs is to design active molecules that have preferable drug-like characteristics. These "drug-like" characteristics include physiochemical properties that affect drug absorption, distribution, metabolism, and excretion (ADME). Compounds with poor ADME profiles will likely fail in vivo due to poor pharmacokinetics and/or other drug delivery related issues. There have been numerous assays developed in order to pre-screen compounds that would likely fail in further development due to poor absorption properties including PAMPA, Caco-2, and MDCK permeability assays. The use of cell-based permeability assays such as Caco-2 and MDCK serve as surrogate indicators of drug absorption and transport, with the two approaches often used interchangeably. We sought to evaluate both approaches in support of anti-malarial drug development. Accordingly, a comparison of both assays was conducted utilizing apparent permeability coefficient (Papp) values determined from liquid chromatography/tandem mass spectrometry (LC-MS) analyses. Both Caco-2 and MDCK permeability assays produced similar Papp results for potential anti-malarial compounds with low and medium permeability. Differences were observed for compounds with high permeability and compounds that were P-gp substrates. Additionally, the utility of MDCK-MDR1 permeability measurements was demonstrated in probing the role of P-glycoprotein transport in Primaquine-Chloroquine drug-drug interactions in comparison with in vivo pharmacokinetic changes. This study provides an in-depth comparison of the Caco-2 and MDCK-MDR1 cell based permeability assays and illustrates the utility of cell-based permeability assays in anti-malarial drug screening/development in regard to understanding transporter mediated changes in drug absorption/distribution.

Product Number
Product Description

Streptomycin sulfate salt, powder
Streptomycin sulfate salt, powder, BioReagent, suitable for cell culture
EPPS, ≥99.5% (titration)
Streptomycin solution, ~1 mg/mL in 1 mM EDTA, analytical standard
Streptomycin sulfate, European Pharmacopoeia (EP) Reference Standard
Streptomycin sulfate salt, powder, BioXtra, suitable for mouse embryo cell culture
Ciclosporin, European Pharmacopoeia (EP) Reference Standard
(±)-CPP, solid
EPPS, BioPerformance Certified, suitable for cell culture, ≥99.5% (titration)
1-Propanesulfonic acid, technical, ≥99.0% (T)
EPPS, BioXtra, ≥99.5% (titration)
Ciclosporin for system suitability, European Pharmacopoeia (EP) Reference Standard

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.